Prophylactic Tamsulosin Use for Prevention of Post-Operative Urinary Retention

Stopped early · Not applicable

Conditions studied: Post-Operative Urinary Retention

In brief

This randomized open-label study will be comprised of 2 cohorts: one control group and one treatment group. The trial will be conducted as an open label randomized trial to evaluate the efficacy of tamsulosin in the prevention of post-operative urinary retention. The study will include pre- and post-surgical evaluations of patients including symptoms of urinary retention and any adverse effects contributable to the study medication.

Key facts

Study ID

NCT02684344

Run by

University of Rochester

People needed

5

Starts

2016-02-01

Expected to finish

2017-12-01

Last updated by the study team

2019-01-23

Who can join

Age: 40 and older. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Any male age 40 or older
• Scheduled to undergo one of the planned surgeries (thoracic, general, or urologic)
• Ability to give informed consent

You may not qualify if…

• Current use of alpha blocker
• Current use of a strong CYP 3A4 inhibitors
• Any allergy to tamsulosin, alpha-blocker medication class, or anaphylaxis allergy to sulfate containing medications
• Patients with any upcoming surgery for cataracts
• Currently enrolled in a clinical trial
• Inability to give informed consent

Where it is running

• University of Rochester — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.